companydata.dkG2B BioSolutions Denmark ApS: Financial statements 2024
CVR: 43237748
G2B BioSolutions Denmark ApS (CVR 43237748) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -9,313 and a net result of DKK -9,563 compared with DKK -10,098 the year before. Equity amounted to DKK 20,340. The solvency ratio was 100%.
- Gross Profit
- -9,313 kr.
- Profit/Loss
- -9,563 kr.
- Equity
- 20,340 kr.
- Total Assets
- 20,340 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9 t. | -10 t. | 20 t. | 0 |
| 2023 | - | -10 t. | -10 t. | 30 t. | 1 |
How creditworthy is G2B BioSolutions Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
G2B BioSolutions Denmark ApS has published its annual report for 2023. Gross profit came to DKK -10,098, and the net result was DKK -10,098.
About G2B BioSolutions Denmark ApS
G2B BioSolutions Denmark ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2022. The company was registered under the industry Levering af kombinerede hjælpetjenester i forbindelse med drift af fast ejendom. In 2024, the company reported a gross profit of DKK -9,313 and a net result of DKK -9,563 compared with DKK -10,098 the year before. Equity amounted to DKK 20,340.